Steven Cohen’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RPRX
Steven Cohen's RPRX Position: Q2 2026 in Review
Steven Cohen reduced its Royalty Pharma (RPRX) stake by 78% in Q2 2026, selling an estimated $20M and leaving 106,549 shares worth $5.97M. The position accounts for 0.01% of the portfolio, ranked #1636.
Steven Cohen first reported a position in RPRX in Q3 2021 and has held it in 13 quarters since. The position peaked at $73.7M in Q1 2022. 640 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.
- Steven Cohen held 106,549 shares of Royalty Pharma worth $5.97M as of Q2 2026.
- Steven Cohen sold 383,469 Royalty Pharma shares in Q2 2026, an estimated $20M.
- Royalty Pharma made up 0.01% of Steven Cohen's portfolio in Q2 2026, its #1636 holding.
- Steven Cohen first reported a position in Royalty Pharma in Q3 2021 and has held it in 13 quarters since.
- Steven Cohen's Royalty Pharma position peaked at $73.7M in Q1 2022.
- 640 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.
Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.